AI-powered agent for clinical notes is now available in the UK after demonstrating significant benefits at NHS Trusts Oracle Health Clinical AI Agent reduces documentationAI-powered agent for clinical notes is now available in the UK after demonstrating significant benefits at NHS Trusts Oracle Health Clinical AI Agent reduces documentation

Oracle Health Clinical AI Agent, Clinical Note Helps UK Doctors Spend More Time on Patient Care

2026/02/12 17:30
5 min read

AI-powered agent for clinical notes is now available in the UK after demonstrating significant benefits at NHS Trusts

Oracle Health Clinical AI Agent reduces documentation time, freeing time for more meaningful patient interaction

LONDON, Feb. 12, 2026 /PRNewswire/ — Following a successful pilot program at several NHS Trusts, Oracle Health today announced its Clinical AI Agent, Clinical Note is now available in the UK. The new AI solution allows caregivers at the NHS and private practices to use an ambient voice and screen-driven assistant to draft patient notes, so they can reduce administrative tasks and devote more time to patient care. Trusts participating in the pilot program, including Barts Health NHS Trust, Imperial College Healthcare NHS Trust, and Milton Keynes University Hospital, are now deploying the solution more broadly across their organizations.

The UK Government’s 10-Year Health Plan, titled “Fit for the Future,” aims to seize the opportunities provided by new technologies, AI, medicines, and innovations to deliver better care for all patients. As a leading electronic health record (EHR) provider, Oracle Health supports this vision, and the general availability of Oracle Health Clinical AI Agent, Clinical Note will help deliver on it. Oracle Health’s AI-powered tools come at a critical time for the NHS as it looks to reduce waiting times and bureaucratic processes, underscoring the need for solutions that seamlessly integrate into clinician workflows and help give doctors and nurses their time back to focus on patients.

With Oracle Health Clinical AI Agent, Clinical Note, clinicians no longer have to spend time sifting through drop down menus and typing on their laptops to document patient visits. Instead, Oracle Health Clinical AI Agent, Clinical Note automatically drafts structured notes from patient-clinician interactions, so doctors only have to review and approve the notes. This reduces the administrative work that contributes to clinician burnout and enables them to focus on the patient during a visit.

Oracle Health Clinical AI Agent, Clinical Note Earns Praise from NHS Organisations

“As a user of the Clinical AI Agent, it’s been really fantastic. It’s improved the accuracy of my notes and given me a lot of time back. Now, when I see a patient, I can spend all my time focusing on them. I can complete my letter and give it to the patient before they even leave the department a few minutes later,” said Robin Kearney, consultant in acute medicine, Milton Keynes University Hospital. “Plus, if another clinician sees the patient, they can write a note immediately so everyone else in the team will know within a few minutes what the plan is for the patient. That’s allowing that patient to get joined up care. That was really difficult before.”

“Our ongoing trial of the Clinical AI Agent has demonstrated the power that ambient voice technology can bring to the NHS,” said Sanjay Gautama, Chief Clinical Information Officer and Caldicott Guardian for Imperial College Healthcare Trust NHS and North West London Integrated Care Board. “It is beneficial for both patient and clinician experiences. Our clinicians can focus on engaging with the patient, knowing that comprehensive and robust notes will be taken. These notes are then available for clinical staff to review, approve, and action appropriate follow-up care.”

“Our clinicians who have been using the Oracle Health Clinical AI Agent have been able to document the patient visit and sign the clinic note in real-time,” said Sarah Jensen, group chief informatics officer, Barts Health NHS Trust. “They just need to download the app on their phone, place it near the patient to record the conversation, and this is processed in the trust system to strip out any chat that is not relevant to diagnosis or treatment.”

A Commitment to Innovation

The general availability of Oracle Health Clinical AI Agent, Clinical Note in the UK builds upon Oracle’s commitment to invest $5 billion over the next five years to meet the rapidly growing demand for its cloud services in the UK. This ongoing investment expands the Oracle Cloud Infrastructure (OCI) footprint in the UK and supports the Government’s vision to drive AI innovation and adoption, enabling more organisations across the UK, including those in healthcare, to leverage Oracle’s comprehensive AI and cloud computing services.

“The healthcare industry is grappling with workforce shortages and overloaded clinicians on a global scale. By embedding advanced AI-powered capabilities into their workflows, we are directly tackling the administrative burden that contributes to burnout and hinders clinicians’ ability to focus on providing patient care,” said Seema Verma, executive vice president and general manager, Oracle Health and Life Sciences. “Bringing these innovative capabilities to the NHS is a key part of our commitment to help empower their doctors, so they can deliver exceptional care.”

Oracle Health Clinical AI Agent, Clinical Note launched in the U.S. just a year ago. It’s now being used in more than 300 organizations and has helped save doctors more than 200,000 hours and reduce the average documentation time per patient by approximately 40 percent.

“The launch of Oracle Health’s Clinical AI Agent in the UK reflects continued investment in AI-enabled clinical tools, underscoring the increasing role of AI in supporting clinical workflows, addressing operational efficiency, and informing more data-driven approaches to patient care,” said Mutaz Shegewi, senior research director, Worldwide Healthcare Provider AI, Platforms and Technologies, IDC.

For more information about Oracle Health Clinical AI Agent, Clinical Note, visit https://www.oracle.com/health/clinical-suite/clinical-ai-agent.

About Oracle
Oracle offers integrated suites of applications plus secure, autonomous infrastructure in the Oracle Cloud. For more information about Oracle (NYSE: ORCL), please visit us at www.oracle.com.

Trademarks
Oracle, Java, MySQL and NetSuite are registered trademarks of Oracle Corporation. NetSuite was the first cloud company—ushering in the new era of cloud computing.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/oracle-health-clinical-ai-agent-clinical-note-helps-uk-doctors-spend-more-time-on-patient-care-302685830.html

SOURCE Oracle

Market Opportunity
Nowchain Logo
Nowchain Price(NOW)
$0.0008796
$0.0008796$0.0008796
-8.10%
USD
Nowchain (NOW) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.
Tags:

You May Also Like

Ultimea Unveils Skywave X100 Dual: 9.2.6 Wireless Home Theater Launching March 2026

Ultimea Unveils Skywave X100 Dual: 9.2.6 Wireless Home Theater Launching March 2026

RANCHO CUCAMONGA, Calif., Feb. 12, 2026 /PRNewswire/ — Ultimea, a leader in immersive home entertainment, announces the upcoming launch of its next-generation flagship
Share
AI Journal2026/02/13 02:45
Why The Green Bay Packers Must Take The Cleveland Browns Seriously — As Hard As That Might Be

Why The Green Bay Packers Must Take The Cleveland Browns Seriously — As Hard As That Might Be

The post Why The Green Bay Packers Must Take The Cleveland Browns Seriously — As Hard As That Might Be appeared on BitcoinEthereumNews.com. Jordan Love and the Green Bay Packers are off to a 2-0 start. Getty Images The Green Bay Packers are, once again, one of the NFL’s better teams. The Cleveland Browns are, once again, one of the league’s doormats. It’s why unbeaten Green Bay (2-0) is a 8-point favorite at winless Cleveland (0-2) Sunday according to betmgm.com. The money line is also Green Bay -500. Most expect this to be a Packers’ rout, and it very well could be. But Green Bay knows taking anyone in this league for granted can prove costly. “I think if you look at their roster, the paper, who they have on that team, what they can do, they got a lot of talent and things can turn around quickly for them,” Packers safety Xavier McKinney said. “We just got to kind of keep that in mind and know we not just walking into something and they just going to lay down. That’s not what they going to do.” The Browns certainly haven’t laid down on defense. Far from. Cleveland is allowing an NFL-best 191.5 yards per game. The Browns gave up 141 yards to Cincinnati in Week 1, including just seven in the second half, but still lost, 17-16. Cleveland has given up an NFL-best 45.5 rushing yards per game and just 2.1 rushing yards per attempt. “The biggest thing is our defensive line is much, much improved over last year and I think we’ve got back to our personality,” defensive coordinator Jim Schwartz said recently. “When we play our best, our D-line leads us there as our engine.” The Browns rank third in the league in passing defense, allowing just 146.0 yards per game. Cleveland has also gone 30 straight games without allowing a 300-yard passer, the longest active streak in the NFL.…
Share
BitcoinEthereumNews2025/09/18 00:41
Unlocking Massive Value: Curve Finance Revenue Sharing Proposal for CRV Holders

Unlocking Massive Value: Curve Finance Revenue Sharing Proposal for CRV Holders

BitcoinWorld Unlocking Massive Value: Curve Finance Revenue Sharing Proposal for CRV Holders The dynamic world of decentralized finance (DeFi) is constantly evolving, bringing forth new opportunities and innovations. A significant development is currently unfolding at Curve Finance, a leading decentralized exchange (DEX). Its founder, Michael Egorov, has put forth an exciting proposal designed to offer a more direct path for token holders to earn revenue. This initiative, centered around a new Curve Finance revenue sharing model, aims to bolster the value for those actively participating in the protocol’s governance. What is the “Yield Basis” Proposal and How Does it Work? At the core of this forward-thinking initiative is a new protocol dubbed Yield Basis. Michael Egorov introduced this concept on the CurveDAO governance forum, outlining a mechanism to distribute sustainable profits directly to CRV holders. Specifically, it targets those who stake their CRV tokens to gain veCRV, which are essential for governance participation within the Curve ecosystem. Let’s break down the initial steps of this innovative proposal: crvUSD Issuance: Before the Yield Basis protocol goes live, $60 million in crvUSD will be issued. Strategic Fund Allocation: The funds generated from the sale of these crvUSD tokens will be strategically deployed into three distinct Bitcoin-based liquidity pools: WBTC, cbBTC, and tBTC. Pool Capping: To ensure balanced risk and diversified exposure, each of these pools will be capped at $10 million. This carefully designed structure aims to establish a robust and consistent income stream, forming the bedrock of a sustainable Curve Finance revenue sharing mechanism. Why is This Curve Finance Revenue Sharing Significant for CRV Holders? This proposal marks a pivotal moment for CRV holders, particularly those dedicated to the long-term health and governance of Curve Finance. Historically, generating revenue for token holders in the DeFi space can often be complex. The Yield Basis proposal simplifies this by offering a more direct and transparent pathway to earnings. By staking CRV for veCRV, holders are not merely engaging in governance; they are now directly positioned to benefit from the protocol’s overall success. The significance of this development is multifaceted: Direct Profit Distribution: veCRV holders are set to receive a substantial share of the profits generated by the Yield Basis protocol. Incentivized Governance: This direct financial incentive encourages more users to stake their CRV, which in turn strengthens the protocol’s decentralized governance structure. Enhanced Value Proposition: The promise of sustainable revenue sharing could significantly boost the inherent value of holding and staking CRV tokens. Ultimately, this move underscores Curve Finance’s dedication to rewarding its committed community and ensuring the long-term vitality of its ecosystem through effective Curve Finance revenue sharing. Understanding the Mechanics: Profit Distribution and Ecosystem Support The distribution model for Yield Basis has been thoughtfully crafted to strike a balance between rewarding veCRV holders and supporting the wider Curve ecosystem. Under the terms of the proposal, a substantial portion of the value generated by Yield Basis will flow back to those who contribute to the protocol’s governance. Returns for veCRV Holders: A significant share, specifically between 35% and 65% of the value generated by Yield Basis, will be distributed to veCRV holders. This flexible range allows for dynamic adjustments based on market conditions and the protocol’s performance. Ecosystem Reserve: Crucially, 25% of the Yield Basis tokens will be reserved exclusively for the Curve ecosystem. This allocation can be utilized for various strategic purposes, such as funding ongoing development, issuing grants, or further incentivizing liquidity providers. This ensures the continuous growth and innovation of the platform. The proposal is currently undergoing a democratic vote on the CurveDAO governance forum, giving the community a direct voice in shaping the future of Curve Finance revenue sharing. The voting period is scheduled to conclude on September 24th. What’s Next for Curve Finance and CRV Holders? The proposed Yield Basis protocol represents a pioneering approach to sustainable revenue generation and community incentivization within the DeFi landscape. If approved by the community, this Curve Finance revenue sharing model has the potential to establish a new benchmark for how decentralized exchanges reward their most dedicated participants. It aims to foster a more robust and engaged community by directly linking governance participation with tangible financial benefits. This strategic move by Michael Egorov and the Curve Finance team highlights a strong commitment to innovation and strengthening the decentralized nature of the protocol. For CRV holders, a thorough understanding of this proposal is crucial for making informed decisions regarding their staking strategies and overall engagement with one of DeFi’s foundational platforms. FAQs about Curve Finance Revenue Sharing Q1: What is the main goal of the Yield Basis proposal? A1: The primary goal is to establish a more direct and sustainable way for CRV token holders who stake their tokens (receiving veCRV) to earn revenue from the Curve Finance protocol. Q2: How will funds be generated for the Yield Basis protocol? A2: Initially, $60 million in crvUSD will be issued and sold. The funds from this sale will then be allocated to three Bitcoin-based pools (WBTC, cbBTC, and tBTC), with each pool capped at $10 million, to generate profits. Q3: Who benefits from the Yield Basis revenue sharing? A3: The proposal states that between 35% and 65% of the value generated by Yield Basis will be returned to veCRV holders, who are CRV stakers participating in governance. Q4: What is the purpose of the 25% reserve for the Curve ecosystem? A4: This 25% reserve of Yield Basis tokens is intended to support the broader Curve ecosystem, potentially funding development, grants, or other initiatives that contribute to the platform’s growth and sustainability. Q5: When is the vote on the Yield Basis proposal? A5: A vote on the proposal is currently underway on the CurveDAO governance forum and is scheduled to run until September 24th. If you found this article insightful and valuable, please consider sharing it with your friends, colleagues, and followers on social media! Your support helps us continue to deliver important DeFi insights and analysis to a wider audience. To learn more about the latest DeFi market trends, explore our article on key developments shaping decentralized finance institutional adoption. This post Unlocking Massive Value: Curve Finance Revenue Sharing Proposal for CRV Holders first appeared on BitcoinWorld.
Share
Coinstats2025/09/18 00:35